Contineum Therapeutics(CTNM) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

7.480
-0.430-5.44%

Trading Mar 26 10:55 ET

193.52MMarket Cap-4.58P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Contineum Therapeutics Appoints Diego Miralles to Board
TipRanksMar 17 16:42 ET
Contineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Bd of Directors
Dow JonesMar 17 16:06 ET
JonesTrading Initiates Contineum Therapeutics(CTNM.US) With Buy Rating, Announces Target Price $23
Moomoo NewsMar 13 18:31 ET · Ratings
Buy Rating for Contineum Therapeutics: Promising Pipeline and Market Opportunities
TipRanksMar 13 10:35 ET
Express News | Contineum Therapeutics Inc : Jonestrading Initiates Coverage With Buy Rating; Price Target $23
ReutersMar 13 08:33 ET
Institutional Investors in Contineum Therapeutics, Inc. (NASDAQ:CTNM) Have Had a Wonderful Week After Share Price Increased 24%
Yahoo FinanceMar 13 08:20 ET

Comments

Teddy123

Mar 7 05:10

Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones

$Contineum Therapeutics (CTNM.US)$
Can Contineum's $204M War Chest Deliver 6 Clinical Trial Wins? Key Dates Revealed

Can’t Trade 4Shit

Apr 19, 2024 16:23

$Contineum Therapeutics (CTNM.US)$what am i missing?

Jaguar8

Apr 5, 2024 11:56

$Contineum Therapeutics (CTNM.US)$
NEWS
Contineum Therapeutics, Inc. announces pricing of IPO, offering 6,875,000 shares of Class A common stock at $16.00 per share, expecting gross proceeds of $110.0 million. Shares to trade on Nasdaq under symbol 'CTNM'.